Norovirus

Back

Practice Essentials

Norovirus, formerly referred to as Norwalk virus, is a very contagious virus that causes acute gastroenteritis. People of all ages can get infected and sick with norovirus. The most common symptoms of norovirus are diarrhea, vomiting, nausea, and stomach pain. Other symptoms include fever, headache, and body ache. About 50% of cases of foodborne gastroenteritis in United States are caused by norovirus. Worldwide, about 1 out of every 5 cases of acute gastroenteritis is caused by norovirus.

The image below depicts the norovirus genomic structure and capsid domains.



View Image

The norovirus genomic structure and capsid domains.

Signs and symptoms

Symptomatic norovirus gastroenteritis typically develops 12-48 hours after ingestion of contaminated food or water or after contact with an infected individual. Symptoms typically last for 24-72 hours.

Symptoms include the following:

Focal tenderness and peritoneal signs are absent in abdominal examination. Vital signs in norovirus gastroenteritis include the following:

See Clinical Presentation for more detail.

Diagnosis

Laboratory studies

Norovirus infection can be detected via the following studies:

Serum antibody titers can be detected within 2 weeks of illness. During norovirus infection, immunoglobulin M (IgM) to norovirus has been found to be more specific than IgG.[2]

Imaging studies

Imaging for isolated, uncomplicated gastroenteritis is not required. In patients with severe symptoms in whom acute abdomen is suspected and in those with preexisting disorders such as inflammatory bowel disease, abdominal radiography or computed tomography scanning should be performed.

New strain

In January 2013, the US Centers for Disease Control and Prevention (CDC) reported that a new norovirus strain, GII.4 Sydney, which was first detected in Australia, had spread to the United States. During the last 4 months of 2012, GII.4 Sydney accounted for 53% of 266 norovirus outbreaks in the United States, with roughly half of them having resulted from direct person-to-person transmission and another 20% having been foodborne. In general, GII.4 strains are associated with higher rates of hospitalization and death.[3, 4]

See Workup for more detail.

Management

Treatment of norovirus gastroenteritis includes the following:

See Treatment and Medication for more detail.

Background

Norwalk virus was officially renamed norovirus by the International Committee on Taxonomy of Viruses in 2002. The virions contain a single-stranded RNA molecule in round to hexagonal capsids that are 35-39 nm in diameter, with icosahedral symmetry. The surface structure of the capsid is a regular pattern with distinctive features and 32 cup-shaped depressions.[5, 6]

Norovirus was first recognized as a cause of gastroenteritis in 1972, when it was detected in stool samples collected from infected elementary school students and contacts during an outbreak in Norwalk, Ohio, in 1968. It was declared a member of the Caliciviridae family of viruses in 1993.[7] It now is considered the most common cause of epidemic nonbacterial gastroenteritis in the world.

In the 1970s and 1980s, typing of Norwalk-like virus (NLV) relied solely on immunologic methods involving human clinical samples as the source of antigens and antibodies. These methods had serious limitations in accuracy and reproducibility and never provided a reliable scheme for antigenic classification of strains. In the 1990s, however, newer molecular techniques to amplify, sequence, and express the genome of NLV strains allowed researchers to genetically and antigenically characterize NLV strains.[8]

The norovirus genus contains more than 40 different strains that are divided into 5 genogroups based on sequence similarity. Viruses in genogroups I, II, and IV are primarily human pathogens, although genogroup II contains a porcine-specific virus. Viruses in genogroup III and V infect bovine and murine species, respectively. Each genogroup is further subdivided into genoclusters based on sequence similarity.[9]

The genome consists of single-stranded RNA of 7.3-7.7 kilobases. It encodes 3 open reading frames (ORFs). ORF 1 is the largest (approximately 1700 amino acids) and expressed as a nonstructural polyprotein precursor that is cleaved by the viral 3C-like protease. ORF 2 encodes the viral capsid (550 amino acids) and contains the shell and protruding domains. ORF 3 encodes a small basic protein of unknown function. See the image below.



View Image

The norovirus genomic structure and capsid domains.

Pathophysiology

Noroviruses are transmitted person to person via direct contact, exposure to aerosols, or fecal–oral routes. Noroviruses are highly contagious, with infection requiring fewer than 10 virions (ID50 = 10 virions), leading to disease in 50% of inoculated individuals. The virus is extremely stable in the environment and resists freezing temperatures, heat (up to 60°C), disinfection with chlorine, acidic conditions, vinegar, alcohol, antiseptic hand solutions, and high sugar concentrations. The incubation period is approximately 1-2 days, and symptoms typically last 1-3 days (or longer in immunocompromised individuals). Viral shedding occurs for up to 3 weeks following infection.[10]

Noroviruses bind polymorphic histoblood group antigens (HBGAs) that putatively serve as receptors or cofactors for infection. Strains from different genoclusters bind various HBGAs: Genogroup I viruses preferentially bind blood group A and O antigens, while genogroup II viruses predominantly bind A and B antigens.[11] Individual norovirus strains may be capable of infecting only a subset of the human population, although the diverse binding profiles found within genogroup I and genogroup II viruses likely collectively make nearly all individuals susceptible to norovirus infection.[10] Recurrent infections can occur throughout life because of the great diversity of norovirus strains and the lack of cross-strain or long-term immunity.

Infection is characterized by damage to the microvilli in the small intestine. Upon microscopic investigation, villi are found to be blunted, although the mucosa and epithelium remain intact.[12] A recent study demonstrated increased epithelial cell apoptosis and damage to tight junction proteins.[13] Diarrhea is induced by D-xylose and fat malabsorption, with enzymatic dysfunction observed at the brush border, along with leak flux and anion secretion.[13, 14]  Vomiting is related to virus-mediated changes in gastric motility and delayed gastric emptying. Notably, no histopathologic lesions can be identified in the gastric mucosa of infected patients.[15] Noroviruses do not invade the colon, so fecal leukocytes typically are absent, and hematochezia is rare.

Epidemiology

Frequency

United States

According to a Centers for Disease Control and Prevention (CDC) report updated in March 2021, most norovirus outbreaks in the United States happen from November to April. In years when there is a new strain of the virus, there can be 50% more norovirus illness.

Each year, on average in the United States, norovirus causes[41] :

Multistate outbreak of norovirus illnesses linked to raw oysters from Texas has been reported as of April 11, 2023.[40]  Another multistate outbreak of norovirus illnesses linked to raw oysters from British Columbia was reported as of June, 2022.

Outbreaks have been reported in restaurants, health care facilities, schools, resorts, cruise ships, military ships, and barracks. Viral transmission occurs year-round, with a higher incidence of disease in winter months in temperate climates.[18]

International

Data regarding outbreaks in developing nations are not well quantified, but the outbreak rate in other industrial nations is similar to that of the United States.

Mortality/Morbidity

Norovirus gastroenteritis typically lasts 24-72 hours, with remission occurring without sequelae. Death is extremely rare, except in individuals particularly vulnerable to profound volume depletion.

Age

Norovirus gastroenteritis can occur in individuals of all ages. Studies using norovirus recombinant antigen have suggested an increase in antibody prevalence with advancing age. In 1 study, the prevalence of norovirus immunoglobulin G (IgG) rose during school-aged years, reaching a peak of 70% in persons aged 11-16 years.[19] It should be noted, however, that not all infected individuals sustain detectable antibody responses.

Prognosis

Norovirus gastroenteritis is a self-limiting disease with an excellent prognosis in otherwise healthy individuals.

Patient Education

Patients with norovirus infection should be educated on personal and environmental hygiene, including avoiding/eliminating contaminated foods and water. Ill individuals should refrain from attending school or work.

History

Symptomatic norovirus gastroenteritis typically develops 12-48 hours after ingestion of contaminated food or water or after contact with an infected individual. Symptoms typically last for 24-72 hours.

Symptoms include the following:

Physical

Vital signs include low-grade fever, tachycardia, and possible hypotension with volume depletion.

Abdominal examination reveals the absence of focal tenderness and peritoneal signs.

Causes

Vectors for norovirus infection include the following:

Complications

Significant electrolyte and blood chemistry abnormalities such as hypokalemia, hyponatremia, metabolic alkalosis, and elevated creatinine phosphokinase can occur in patients with pre-existing conditions such as inflammatory bowel disease, renal failure, immunocompromising conditions, and cardiovascular disease. Severe clinical features, including acute renal failure, arrhythmia, and signs of acute organ rejection in renal transplant patients were observed in a university hospital outbreak.[21]

One case of norovirus encephalopathy was reported in a 23-month-old child.[22]

Hemolytic uremic syndrome has been reported in association with norovirus gastroenteritis in a patient with chronic renal failure.[23]

Laboratory Studies

Generally, routine laboratory studies are not helpful in suspected cases of norovirus gastroenteritis. In severe cases of gastroenteritis with volume depletion, electrolytes and blood urea nitrogen and creatinine should be monitored.

The peripheral white blood cell count usually is normal. There may be slight polymorphonuclear leucocytosis and lymphopenia.

The absence of fecal leucocytes and occult blood in stool is helpful in ruling out other enteroinvasive infectious diarrhea processes. Stool culture should be performed to exclude infection with bacterial organisms such as Yersinia, Shigella, Salmonella, and Campylobacter species.[24]

Detection methods include the following:

Imaging Studies

Imaging for isolated uncomplicated gastroenteritis is not required.

In patients with severe symptoms in whom acute abdomen is suspected and in those with pre-existing diseases such as inflammatory bowel disease or other comorbidities, abdominal radiography or CT scanning should be performed.

Other Tests

If the patient is an international traveler, stool testing for ova and parasites and stool culture should be considered.

If the patient is severely immunocompromised (eg, with AIDS), stool tests for Cyclospora, cytomegalovirus (CMV), Isospora, and Cryptosporidium may be considered.

Histologic Findings

The surface area of the villus is reduced (villus blunting), along with the appearance of a dense intraepithelial infiltrate of CD8+ T lymphocytes. An increase in polymononuclear cells in the lamina propria of the small intestine also is observed.

In one study, electrophysiological analyses of duodenal biopsies from patients with norovirus infection showed increased epithelial apoptosis and a reduction in tight junctional protein expression, leading to epithelial barrier dysfunction. This likely contributes to diarrhea during norovirus infection by a leak flux mechanism (ie, ions and water leak from subepithelial capillaries into the intestinal lumen by paracellular diffusion due to increased permeability of tight junctions). Increased anion secretion was another finding in the study.[13] See the image below.



View Image

Hematoxylin and eosin stain of duodenal epithelium.

Medical Care

Oral fluid and electrolyte replacement generally is adequate for the treatment of norovirus infections.

In cases of severe volume depletion, intravenous fluid and electrolyte resuscitation may be necessary.

Symptomatic relief can be achieved using antiemetics for nausea and vomiting and analgesics for myalgias and headache.

Antiperistaltic agents generally should be avoided in cases of infectious diarrhea but could be considered in patients with severe diarrhea.

Consultations

In all epidemic outbreaks (2 or more people who shared a common meal), the local and/or state health department should be contacted for investigation of potential sources.

Diet

Treatment includes the following:

Activity

Activity may be performed as tolerated.

Prevention

In cases of norovirus outbreaks, several measures should be taken to prevent further transmission, as follows:

Clinical trials are in progress for vaccine development. Currently no vaccines against norovirus are available due to wide genetic and antigenic diversity of noroviruses with multiple co-circulated variants of various genotypes.

Medication Summary

Symptoms of norovirus infection usually are self-limited and resolve spontaneously within 24-48 hours. Antidiarrheal agents may be used with caution but should be avoided in children. Over-the-counter analgesics (eg, ibuprofen, acetaminophen) and antiemetics, if prescribed by a physician, can be used for symptomatic relief (drug-specific product labeling should be consulted). Fluid intake is recommended to maintain hydration.

 

Author

Zartash Zafar Khan, MD, FACP, Infectious Disease Consultant

Disclosure: Nothing to disclose.

Coauthor(s)

Michelle A Jaworski, MD, Consulting Staff, Midland Orthopedic Associates

Disclosure: Nothing to disclose.

Todd S Wills, MD, Associate Professor, Department of Medicine, Division of Infectious Disease and International Medicine, Program Director, Infectious Disease Fellowship Program, University of South Florida College of Medicine

Disclosure: Nothing to disclose.

Specialty Editors

Francisco Talavera, PharmD, PhD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Richard B Brown, MD, FACP, Chief, Division of Infectious Diseases, Baystate Medical Center; Professor, Department of Internal Medicine, Tufts University School of Medicine

Disclosure: Nothing to disclose.

Chief Editor

Michael Stuart Bronze, MD, David Ross Boyd Professor and Chairman, Department of Medicine, Stewart G Wolf Endowed Chair in Internal Medicine, Department of Medicine, University of Oklahoma Health Science Center; Master of the American College of Physicians; Fellow, Infectious Diseases Society of America; Fellow of the Royal College of Physicians, London

Disclosure: Nothing to disclose.

Additional Contributors

Joseph R Masci, MD, FACP, FCCP, Professor of Medicine, Professor of Preventive Medicine, Icahn School of Medicine at Mount Sinai; Director of Medicine, Elmhurst Hospital Center

Disclosure: Nothing to disclose.

Mark Martin Huycke, MD, Professor of Medicine, Infectious Diseases Section, University of Oklahoma Health Sciences Center; Chief, Medical Service, Department of Veterans Affairs Medical Center, Oklahoma City

Disclosure: Nothing to disclose.

References

  1. Tian P, Mandrell R. Detection of norovirus capsid proteins in faecal and food samples by a real time immuno-PCR method. J Appl Microbiol. 2006 Mar. 100(3):564-74. [View Abstract]
  2. Brinker JP, Blacklow NR, Jiang X, Estes MK, Moe CL, Herrmann JE. Immunoglobulin M antibody test to detect genogroup II Norwalk-like virus infection. J Clin Microbiol. 1999 Sep. 37(9):2983-6. [View Abstract]
  3. Lowes R. New Norovirus Strain Hits US. Medscape Medical News. Jan 24 2013.
  4. CDC. Notes from the Field: Emergence of New Norovirus Strain GII.4 Sydney—United States, 2012. MMWR. Jan 25 2013. 62(3):55.
  5. www.ncbi.nlm.nih.gov/ICTVdb/ICTVdB/00.012.0.03.htm. 2002;
  6. Shoemaker GK, van Duijn E, Crawford SE, Uetrecht C, Baclayon M, Roos WH, et al. Norwalk virus assembly and stability monitored by mass spectrometry. Mol Cell Proteomics. 2010 Aug. 9(8):1742-51. [View Abstract]
  7. Jiang X, Wang M, Wang K, Estes MK. Sequence and genomic organization of Norwalk virus. Virology. 1993 Jul. 195(1):51-61. [View Abstract]
  8. Ando T, Noel JS, Fankhauser RL. Genetic classification of "Norwalk-like viruses. J Infect Dis. 2000 May. 181 Suppl 2:S336-48. [View Abstract]
  9. Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS. Norovirus classification and proposed strain nomenclature. Virology. 2006 Mar 15. 346(2):312-23. [View Abstract]
  10. Donaldson EF, Lindesmith LC, Lobue AD, Baric RS. Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations. Immunol Rev. 2008 Oct. 225:190-211. [View Abstract]
  11. Huang P, Farkas T, Marionneau S, Zhong W, Ruvoën-Clouet N, Morrow AL, et al. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J Infect Dis. 2003 Jul 1. 188(1):19-31. [View Abstract]
  12. Schreiber DS, Blacklow NR, Trier JS. The mucosal lesion of the proximal small intestine in acute infectious nonbacterial gastroenteritis. N Engl J Med. 1973 Jun 21. 288(25):1318-23. [View Abstract]
  13. Troeger H, Loddenkemper C, Schneider T, Schreier E, Epple HJ, Zeitz M, et al. Structural and functional changes of the duodenum in human norovirus infection. Gut. 2009 Aug. 58(8):1070-7. [View Abstract]
  14. Acute infectious nonbacterial gastroenteritis: etiology and pathogenesis. Ann Intern Med. 1972 Jun. 76(6):993-1008. [View Abstract]
  15. Widerlite L, Trier JS, Blacklow NR, Schreiber DS. Structure of the gastric mucosa in acute infectious bacterial gastroenteritis. Gastroenterology. 1975 Mar. 68(3):425-30. [View Abstract]
  16. Mounts AW, Ando T, Koopmans M, Bresee JS, Noel J, Glass RI. Cold weather seasonality of gastroenteritis associated with Norwalk-like viruses. J Infect Dis. 2000 May. 181 Suppl 2:S284-7. [View Abstract]
  17. Parker SP, Cubitt WD, Jiang XJ, Estes MK. Seroprevalence studies using a recombinant Norwalk virus protein enzyme immunoassay. J Med Virol. 1994 Feb. 42(2):146-50. [View Abstract]
  18. Rockx B, De Wit M, Vennema H, Vinjé J, De Bruin E, Van Duynhoven Y, et al. Natural history of human calicivirus infection: a prospective cohort study. Clin Infect Dis. 2002 Aug 1. 35(3):246-53. [View Abstract]
  19. Mattner F, Sohr D, Heim A, Gastmeier P, Vennema H, Koopmans M. Risk groups for clinical complications of norovirus infections: an outbreak investigation. Clin Microbiol Infect. 2006 Jan. 12(1):69-74. [View Abstract]
  20. Ito S, Takeshita S, Nezu A, Aihara Y, Usuku S, Noguchi Y, et al. Norovirus-associated encephalopathy. Pediatr Infect Dis J. 2006 Jul. 25(7):651-2. [View Abstract]
  21. Sugimoto T, Ogawa N, Aoyama M, Sakaguchi M, Isshiki K, Kanasaki M, et al. Haemolytic uraemic syndrome complicated with norovirus-associated gastroenteritis. Nephrol Dial Transplant. 2007 Jul. 22(7):2098-9. [View Abstract]
  22. Guerrant RL, Shields DS, Thorson SM. Evaluation and diagnosis of acute infectious diarrhea. Am J Med. 1985 Jun 28. 78(6B):91-8. [View Abstract]
  23. Boxman I, Dijkman R, Verhoef L, Maat A, van Dijk G, Vennema H, et al. Norovirus on swabs taken from hands illustrate route of transmission: a case study. J Food Prot. 2009 Aug. 72(8):1753-5. [View Abstract]
  24. Cheng VC, Tai JW, Ho YY, Chan JF. Successful control of norovirus outbreak in an infirmary with the use of alcohol-based hand rub. J Hosp Infect. 2009 Aug. 72(4):370-1. [View Abstract]
  25. Liu P, Yuen Y, Hsiao HM, Jaykus LA, Moe C. Effectiveness of liquid soap and hand sanitizer against Norwalk virus on contaminated hands. Appl Environ Microbiol. 2010 Jan. 76(2):394-9. [View Abstract]
  26. Atmar RL, Estes MK. The epidemiologic and clinical importance of norovirus infection. Gastroenterol Clin North Am. 2006 Jun. 35(2):275-90, viii. [View Abstract]
  27. Blacklow NR, Greenberg HB. Viral gastroenteritis. N Engl J Med. 1991 Jul 25. 325(4):252-64. [View Abstract]
  28. Centers for Disease Control and Prevention (CDC). Multisite outbreak of norovirus associated with a franchise restaurant--Kent County, Michigan, May 2005. MMWR Morb Mortal Wkly Rep. 2006 Apr 14. 55(14):395-7. [View Abstract]
  29. Centers for Disease Control and Prevention (CDC). Norovirus outbreak among evacuees from hurricane Katrina--Houston, Texas, September 2005. MMWR Morb Mortal Wkly Rep. 2005 Oct 14. 54(40):1016-8. [View Abstract]
  30. Centers for Disease Control and Prevention (CDC). Outbreaks of gastroenteritis associated with noroviruses on cruise ships--United States, 2002. MMWR Morb Mortal Wkly Rep. 2002 Dec 13. 51(49):1112-5. [View Abstract]
  31. [Guideline] DuPont HL. Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1997 Nov. 92(11):1962-75. [View Abstract]
  32. Graham DY, Jiang X, Tanaka T. Norwalk virus infection of volunteers: new insights based on improved assays. J Infect Dis. 1994 Jul. 170(1):34-43. [View Abstract]
  33. Greenberg HB, Valdesuso J, Yolken RH. Role of Norwalk virus in outbreaks of nonbacterial gastroenteritis. J Infect Dis. 1979 May. 139(5):564-8. [View Abstract]
  34. Jiang X, Wang M, Graham DY. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol. 1992 Nov. 66(11):6527-32. [View Abstract]
  35. Jääskeläinen AJ, Maunula L. Applicability of microarray technique for the detection of noro- and astroviruses. J Virol Methods. 2006 Sep. 136(1-2):210-6. [View Abstract]
  36. Kaplan JE, Gary GW, Baron RC. Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med. 1982 Jun. 96(6 Pt 1):756-61. [View Abstract]
  37. Moe CL, Gentsch J, Ando T. Application of PCR to detect Norwalk virus in fecal specimens from outbreaks of gastroenteritis. J Clin Microbiol. 1994 Mar. 32(3):642-8. [View Abstract]
  38. Available at https://www.cdc.gov/norovirus/outbreaks/index.html
  39. Available at https://www.cdc.gov/norovirus/trends-outbreaks/burden-US.html

The norovirus genomic structure and capsid domains.

The norovirus genomic structure and capsid domains.

Hematoxylin and eosin stain of duodenal epithelium.

Hematoxylin and eosin stain of duodenal epithelium.

The norovirus genomic structure and capsid domains.